From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. Eli Lilly saw…
Something Grim Is Happening to People Who Go Off GLP-1s
Many people who successfully lost weight on Ozempic and other GLP-1 agonist drugs are having trouble weaning themselves off…